Felicia Leineweber, PA
Physician Assistant · Frederick, MDNPI 1962409854
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Mallinckrodt Hospital Products Inc. at 25.4% of the total.
Across 13 payments — averaging $27.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$91
- AbbVie$56
- Otsuka America Pharmaceutical, Inc.$42
- Fresenius USA Marketing, Inc.$40
- GSK$30
- Boston Scientific$25
- plus $75 from 4 others
What the payments were for
- Food & beverage$359100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 1 | $91 |
| AbbVie | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Fresenius USA Marketing, Inc. | 2 | $40 |
| GSK | 1 | $30 |
| Boston Scientific | 1 | $25 |
| Johnson & Johnson | 1 | $23 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $21 |
| Smith+Nephew | 1 | $16 |
| Gilead | 1 | $15 |
How this compares
$359 in reported general payments places this provider in the 60th percentile of 2,567 physician assistant providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 15 | $174 |
| Atorvastatin Calcium | 29 | $121 |
| Azithromycin | 21 | $119 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $116 |
| Cephalexin | 14 | $108 |
| Prednisone | 26 | $103 |
| Sucralfate | 14 | $85 |
| Tamsulosin Hcl | 14 | $77 |
| Hydralazine Hcl | 11 | $59 |
| Furosemide | 16 | $55 |
| Losartan Potassium | 12 | $49 |
| Amlodipine Besylate | 12 | $44 |
| Oxycodone Hcl | 13 | $35 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Frederick
- Jinhui YuanFrederick$21K
- Heather DemoryFrederick$12K
- Jessie MallalieuFrederick$10K
- Margaret JoyceTowson$220K
- Kara CossisBaltimore$177K
- Garland JamesSilver Spring$86K
- Melissa BearekmanBaltimore$81K
- Brittany YerkesSalisbury$81K
- Amy CollierTimonium$29K
- Hannah JohnsonNottingham$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.